These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24592667)

  • 1. The psychoactive effects of psychiatric medication: the elephant in the room.
    Moncrieff J; Cohen D; Porter S
    J Psychoactive Drugs; 2013; 45(5):409-15. PubMed ID: 24592667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians.
    Mark TL
    CNS Drugs; 2010 Apr; 24(4):319-26. PubMed ID: 20297856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychoactive drug prescribing in Japan: epistemological and bioethical considerations.
    Sakai A
    J Med Philos; 1991 Apr; 16(2):139-53; discussion 155-60. PubMed ID: 2061699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan.
    Tanibuchi Y; Matsumoto T; Funada D; Shimane T
    Neuropsychopharmacol Rep; 2018 Dec; 38(4):189-196. PubMed ID: 30341809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of psychiatric inpatients diagnosed with mental and behavioral disorders caused by psychoactive substances (F11-19 block), with a focus on NPS and psychiatric co-morbidities.
    Engelgardt P; Krzyżanowski M; Piotrowski P; Borkowska-Sztachańska M; Wasilewska A; Kowalkowski T
    Int J Occup Med Environ Health; 2020 Mar; 33(2):125-136. PubMed ID: 31942874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary care and psychoactive drugs. Some reflections].
    Vender S
    Recenti Prog Med; 1991 Dec; 82(12):661-4. PubMed ID: 1815301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuing Psychiatric Medications: A Survey of Long-Term Users.
    Ostrow L; Jessell L; Hurd M; Darrow SM; Cohen D
    Psychiatr Serv; 2017 Dec; 68(12):1232-1238. PubMed ID: 28712356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric diagnoses and perceived health problems in a sample of working Swedes treated with psychoactive medications.
    Allgulander C; Evanoff B
    J Psychoactive Drugs; 1990; 22(4):467-78. PubMed ID: 2096191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Practical Approach to Avoiding Cardiovascular Adverse Effects of Psychoactive Medications.
    Brouillette J; Nattel S
    Can J Cardiol; 2017 Dec; 33(12):1577-1586. PubMed ID: 29173600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychoactive substances in natural and unnatural deaths in Norway and Sweden - a study on victims of suicide and accidents compared with natural deaths in psychiatric patients.
    Gravensteen IK; Ekeberg Ø; Thiblin I; Helweg-Larsen K; Hem E; Rogde S; Tøllefsen IM
    BMC Psychiatry; 2019 Jan; 19(1):33. PubMed ID: 30658618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between psychoactive medications and delirium in hospitalized patients: a critical review.
    Gaudreau JD; Gagnon P; Roy MA; Harel F; Tremblay A
    Psychosomatics; 2005; 46(4):302-16. PubMed ID: 16000673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing misuse of novel psychoactive substances.
    Solomon D; Grewal P; Taylor C; Solomon B
    Nurs Times; 2014 May 28-Jun 3; 110(22):12-5. PubMed ID: 24984370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicologic Emergencies in Patients with Mental Illness: When Medications Are No Longer Your Friends.
    Greene S; AufderHeide E; French-Rosas L
    Psychiatr Clin North Am; 2017 Sep; 40(3):519-532. PubMed ID: 28800806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychoactive drug consumption: performance-enhancing behaviour and pharmacodependence in workers.
    Ngoundo-Mbongue TB; Niezborala M; Sulem P; Briant-Vincens D; Bancarel Y; Jansou P; Chastan E; Montastruc JL; Lapeyre-Mestre M
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):81-9. PubMed ID: 15386725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex and age differences in ED patients with mental and behavioral disorders due to psychoactive substance use.
    Le Querrec F; Bounes V; Mestre ML; Azema O; Longeaux N; Gallart JC
    Am J Emerg Med; 2015 Nov; 33(11):1612-6. PubMed ID: 26324006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New psychoactive drugs.
    Murray JB
    Genet Soc Gen Psychol Monogr; 1985 Nov; 111(4):429-53. PubMed ID: 2873081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons for psychiatric medication prescription for new nursing home residents.
    Molinari VA; Chiriboga DA; Branch LG; Schinka J; Schonfeld L; Kos L; Mills WL; Krok J; Hyer K
    Aging Ment Health; 2011 Sep; 15(7):904-12. PubMed ID: 21702727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users.
    Malone DA; Dimeff RJ; Lombardo JA; Sample RH
    Clin J Sport Med; 1995; 5(1):25-31. PubMed ID: 7614077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel psychoactive substances in young adults with and without psychiatric comorbidities.
    Martinotti G; Lupi M; Acciavatti T; Cinosi E; Santacroce R; Signorelli MS; Bandini L; Lisi G; Quattrone D; Ciambrone P; Aguglia A; Pinna F; Calò S; Janiri L; di Giannantonio M
    Biomed Res Int; 2014; 2014():815424. PubMed ID: 25133182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.